Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Real time assays for quantifying cytotoxicity with single cell resolution.

Hsiao SC, Liu H, Holstlaw TA, Liu C, Francis CY, Francis MB.

PLoS One. 2013 Jun 24;8(6):e66739. doi: 10.1371/journal.pone.0066739. Print 2013.

2.

Real-time cytotoxicity assays in human whole blood.

Hsiao CW, Lo YT, Liu H, Hsiao SC.

J Vis Exp. 2014 Nov 7;(93):e51941. doi: 10.3791/51941.

3.

Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide.

Lee-MacAry AE, Ross EL, Davies D, Laylor R, Honeychurch J, Glennie MJ, Snary D, Wilkinson RW.

J Immunol Methods. 2001 Jun 1;252(1-2):83-92.

PMID:
11334968
4.

Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores.

Wilkinson RW, Lee-MacAry AE, Davies D, Snary D, Ross EL.

J Immunol Methods. 2001 Dec 1;258(1-2):183-91.

PMID:
11684135
5.

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood.

Iida S, Kuni-Kamochi R, Mori K, Misaka H, Inoue M, Okazaki A, Shitara K, Satoh M.

BMC Cancer. 2009 Feb 18;9:58. doi: 10.1186/1471-2407-9-58.

6.

Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.

Liu Z, Lee FT, Hanai N, Smyth FE, Burgess AW, Old LJ, Scott AM.

Cancer Immun. 2002 Oct 7;2:13.

7.

A flow cytometry-based assay for the evaluation of antibody-dependent cell-mediated cytotoxicity (ADCC) in cancer cells.

Salinas-Jazmín N, Hisaki-Itaya E, Velasco-Velázquez MA.

Methods Mol Biol. 2014;1165:241-52. doi: 10.1007/978-1-4939-0856-1_16.

PMID:
24839029
9.

A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells.

Flieger D, Gruber R, Schlimok G, Reiter C, Pantel K, Riethmüller G.

J Immunol Methods. 1995 Mar 13;180(1):1-13.

PMID:
7897241
10.

High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism.

Mishima Y, Terui Y, Mishima Y, Kuniyoshi R, Matsusaka S, Mikuniya M, Kojima K, Hatake K.

Int Immunol. 2012 Aug;24(8):477-83. doi: 10.1093/intimm/dxs048. Epub 2012 Mar 21.

PMID:
22438420
11.

Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity.

van Meerten T, van Rijn RS, Hol S, Hagenbeek A, Ebeling SB.

Clin Cancer Res. 2006 Jul 1;12(13):4027-35.

12.

Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity.

Kramski M, Schorcht A, Johnston AP, Lichtfuss GF, Jegaskanda S, De Rose R, Stratov I, Kelleher AD, French MA, Center RJ, Jaworowski A, Kent SJ.

J Immunol Methods. 2012 Oct 31;384(1-2):51-61. doi: 10.1016/j.jim.2012.07.006. Epub 2012 Jul 24.

PMID:
22841577
13.

Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.

Niwa R, Hatanaka S, Shoji-Hosaka E, Sakurada M, Kobayashi Y, Uehara A, Yokoi H, Nakamura K, Shitara K.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6248-55.

14.

Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.

Wang W, Nishioka Y, Ozaki S, Jalili A, Verma VK, Hanibuchi M, Abe S, Minakuchi K, Matsumoto T, Sone S.

Lung Cancer. 2009 Jan;63(1):23-31. doi: 10.1016/j.lungcan.2008.04.009. Epub 2008 Jun 3.

PMID:
18524412
15.

In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity.

Forthal DN, Landucci G.

J Immunol Methods. 1998 Nov 1;220(1-2):129-38.

PMID:
9839934
16.
20.

Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.

Peter HH, Knoop F, Kalden JR.

Z Immunitatsforsch Exp Klin Immunol. 1976 Apr;151(3):263-81.

PMID:
134545

Supplemental Content

Support Center